208 related articles for article (PubMed ID: 18951493)
1. Innate and adaptive immune activation in the brain of MPS IIIB mouse model.
DiRosario J; Divers E; Wang C; Etter J; Charrier A; Jukkola P; Auer H; Best V; Newsom DL; McCarty DM; Fu H
J Neurosci Res; 2009 Mar; 87(4):978-90. PubMed ID: 18951493
[TBL] [Abstract][Full Text] [Related]
2. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.
Zheng Y; Ryazantsev S; Ohmi K; Zhao HZ; Rozengurt N; Kohn DB; Neufeld EF
Mol Genet Metab; 2004 Aug; 82(4):286-95. PubMed ID: 15308126
[TBL] [Abstract][Full Text] [Related]
3. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM
J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889
[TBL] [Abstract][Full Text] [Related]
4. Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB.
Villani GR; Gargiulo N; Faraonio R; Castaldo S; Gonzalez Y Reyero E; Di Natale P
J Neurosci Res; 2007 Feb; 85(3):612-22. PubMed ID: 17139681
[TBL] [Abstract][Full Text] [Related]
5. Immune activation or immunomodulation in the brains of MPS IIIB mice? Commentary on "Innate and adaptive immune activation in the brain of MPS IIIB mouse model".
Archer LD; Langford K; Bigger B; Fildes JE
J Neurosci Res; 2010 Feb; 88(2):233. PubMed ID: 19746428
[No Abstract] [Full Text] [Related]
6. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
Yogalingam G; Hopwood JJ
Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
[TBL] [Abstract][Full Text] [Related]
7. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B.
Garbuzova-Davis S; Klasko SK; Sanberg PR
J Comp Neurol; 2009 Jul; 515(1):93-101. PubMed ID: 19399896
[TBL] [Abstract][Full Text] [Related]
8. Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer.
Villani GR; Follenzi A; Vanacore B; Di Domenico C; Naldini L; Di Natale P
Biochem J; 2002 Jun; 364(Pt 3):747-53. PubMed ID: 12049639
[TBL] [Abstract][Full Text] [Related]
9. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice.
Mohammed EE; Snella EM; Rutz-Mendicino MM; Echevarria FD; Awedikian R; Whitley EM; Ellinwood NM
Mol Genet Metab; 2012 Sep; 107(1-2):129-35. PubMed ID: 22867887
[TBL] [Abstract][Full Text] [Related]
10. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.
Holley RJ; Ellison SM; Fil D; O'Leary C; McDermott J; Senthivel N; Langford-Smith AWW; Wilkinson FL; D'Souza Z; Parker H; Liao A; Rowlston S; Gleitz HFE; Kan SH; Dickson PI; Bigger BW
Brain; 2018 Jan; 141(1):99-116. PubMed ID: 29186350
[TBL] [Abstract][Full Text] [Related]
11. Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments.
Langford-Smith A; Malinowska M; Langford-Smith KJ; Wegrzyn G; Jones S; Wynn R; Wraith JE; Wilkinson FL; Bigger BW
Genes Brain Behav; 2011 Aug; 10(6):673-82. PubMed ID: 21635693
[TBL] [Abstract][Full Text] [Related]
12. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.
Ohmi K; Greenberg DS; Rajavel KS; Ryazantsev S; Li HH; Neufeld EF
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1902-7. PubMed ID: 12576554
[TBL] [Abstract][Full Text] [Related]
13. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR
Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810
[TBL] [Abstract][Full Text] [Related]
14. Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA.
Roberts AL; Rees MH; Klebe S; Fletcher JM; Byers S
Mol Genet Metab; 2007; 92(1-2):115-21. PubMed ID: 17681480
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological and Histological Characterization of Rod-Cone Retinal Degeneration and Microglia Activation in a Mouse Model of Mucopolysaccharidosis Type IIIB.
Tse DY; Lotfi P; Simons DL; Sardiello M; Wu SM
Sci Rep; 2015 Nov; 5():17143. PubMed ID: 26607664
[TBL] [Abstract][Full Text] [Related]
16. Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response.
Killedar S; Dirosario J; Divers E; Popovich PG; McCarty DM; Fu H
J Neuroinflammation; 2010 Jul; 7():39. PubMed ID: 20637096
[TBL] [Abstract][Full Text] [Related]
17. Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B.
Yu WH; Zhao KW; Ryazantsev S; Rozengurt N; Neufeld EF
Mol Genet Metab; 2000 Dec; 71(4):573-80. PubMed ID: 11136549
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.
Crawley AC; Gliddon BL; Auclair D; Brodie SL; Hirte C; King BM; Fuller M; Hemsley KM; Hopwood JJ
Brain Res; 2006 Aug; 1104(1):1-17. PubMed ID: 16828069
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B.
Aronovich EL; Johnston JM; Wang P; Giger U; Whitley CB
Genomics; 2001 Jun; 74(3):299-305. PubMed ID: 11414757
[TBL] [Abstract][Full Text] [Related]
20. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery.
Fu H; Samulski RJ; McCown TJ; Picornell YJ; Fletcher D; Muenzer J
Mol Ther; 2002 Jan; 5(1):42-9. PubMed ID: 11786044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
